Biochemical effects of psychotomimetic anticholinergic drugs.
D000244:Adenosine Diphosphate / Q000378:metabolism; D000249:Adenosine Monophosphate / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D001224:Aspartic Acid / Q000378:metabolism; D002118:Calcium / Q000378:metabolism; D002540:Cerebral Cortex / Q000187:drug effects / Q000378:metabolism*; D004558:Electric Stimulation; D005947:Glucose / Q000378:metabolism; D005958:Glucosephosphates / Q000378:metabolism; D005971:Glutamates / Q000378:metabolism; D006019:Glycolysis / Q000187:drug effects*; D006213:Hallucinogens / Q000494:pharmacology*; D007773:Lactates / Q000378:metabolism; D008928:Mitochondria / Q000378:metabolism; D010101:Oxygen Consumption / Q000187:drug effects; D010276:Parasympatholytics / Q000494:pharmacology*; D010710:Phosphates / Q000378:metabolism; D011188:Potassium / Q000378:metabolism; D011743:Pyrimidines / Q000494:pharmacology; D011773:Pyruvates / Q000378:metabolism; D051381:Rats
D005958:Glucosephosphates; D005971:Glutamates; D006213:Hallucinogens; D007773:Lactates; D010276:Parasympatholytics; D010710:Phosphates; D011743:Pyrimidines; D011773:Pyruvates; D001224:Aspartic Acid; D000249:Adenosine Monophosphate; D000244:Adenosine Diphosphate; D000255:Adenosine Triphosphate; D005947:Glucose; D011188:Potassium; D002118:Calcium